Braveheart Bio
Tracked across 2 events · 31 articles · First seen Jul 06, 2026 · Last active Aug 06, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Braveheart Bio is the issuer of the IPO, raising $382.5 million in gross proceeds to fund development of its lead candidate BHB-1893. The successful pricing and expected listing on Nasdaq provide the company with capital and public market access.
Aug 06, 2026 · 6 articles
Business
Impact: Braveheart Bio is among biotechs queuing to list, potentially benefiting from the positive IPO climate.
Jul 06, 2026 · 25 articles
ERGEN INTELLIGENCE
Track Braveheart Bio live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard